Exchange Traded Concepts, LLC Veracyte, Inc. Transaction History

Exchange Traded Concepts, LLC

$4.18 Billion
Q3 2024

A detailed history of Exchange Traded Concepts, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 90,843 shares of VCYT stock, worth $3.94 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

90,843

Previous 132,301 31.34%

Holding current value

$3.94 Million

Previous $2.87 Million 7.85%

% of portfolio

0.07%

Previous 0.07%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$21.0 - $35.25 $870,618 - $1.46 Million	-41,458 Reduced 31.34%	90,843 $3.09 Million
Q2 2024 Aug 13, 2024	SELL	$18.86 - $23.55 $228,319 - $285,096	-12,106 Reduced 8.38%	132,301 $2.87 Million
Q1 2024 Apr 15, 2024	BUY	$21.0 - $29.1 $1.06 Million - $1.47 Million	50,506 Added 53.79%	144,407 $3.2 Million
Q4 2023 Jan 05, 2024	BUY	$19.72 - $28.68 $265,865 - $386,663	13,482 Added 16.76%	93,901 $2.58 Million
Q3 2023 Oct 18, 2023	BUY	$22.33 - $29.92 $267,200 - $358,022	11,966 Added 17.48%	80,419 $1.8 Million
Q2 2023 Jul 20, 2023	BUY	$20.96 - $26.99 $50,199 - $64,641	2,395 Added 3.63%	68,453 $1.74 Million
Q1 2023 Apr 12, 2023	BUY	$20.58 - $27.89 $181,186 - $245,543	8,804 Added 15.38%	66,058 $1.47 Million
Q4 2022 Jan 17, 2023	SELL	$15.31 - $29.94 $396,682 - $775,745	-25,910 Reduced 31.16%	57,254 $1.36 Million
Q3 2022 Oct 07, 2022	SELL	$16.58 - $27.9 $517,196 - $870,312	-31,194 Reduced 27.28%	83,164 $1.38 Million
Q2 2022 Jul 20, 2022	BUY	$15.45 - $29.52 $93,812 - $179,245	6,072 Added 5.61%	114,358 $2.28 Million
Q1 2022 Apr 26, 2022	BUY	$21.94 - $42.51 $292,416 - $566,573	13,328 Added 14.04%	108,286 $2.99 Million
Q4 2021 Jan 13, 2022	BUY	$36.09 - $53.79 $479,419 - $714,546	13,284 Added 16.26%	94,958 $3.91 Million
Q3 2021 Oct 18, 2021	SELL	$35.62 - $52.97 $1.12 Million - $1.66 Million	-31,353 Reduced 27.74%	81,674 $3.79 Million
Q2 2021 Jul 30, 2021	BUY	$32.94 - $56.62 $2.39 Million - $4.11 Million	72,637 Added 179.84%	113,027 $4.52 Million
Q1 2021 Apr 20, 2021	BUY	$44.47 - $81.38 $866,320 - $1.59 Million	19,481 Added 93.17%	40,390 $2.17 Million
Q4 2020 Jan 19, 2021	SELL	$32.49 - $61.88 $64,817 - $123,450	-1,995 Reduced 8.71%	20,909 $1.02 Million
Q3 2020 Oct 30, 2020	BUY	$26.73 - $35.67 $210,953 - $281,507	7,892 Added 52.57%	22,904 $744,000
Q2 2020 Jul 15, 2020	BUY	$19.49 - $28.11 $174,708 - $251,978	8,964 Added 148.21%	15,012 $389,000
Q1 2020 Apr 14, 2020	BUY	$16.13 - $30.17 $50,212 - $93,919	3,113 Added 106.06%	6,048 $147,000
Q4 2019 Jan 22, 2020	BUY	$20.78 - $29.99 $60,989 - $88,020	2,935 New	2,935 $82,000

Others Institutions Holding VCYT

# of Institutions

308

Shares Held

81.8M

Call Options Held

134K

Put Options Held

13.3K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $3.1B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.

Account

Exchange Traded Concepts, LLC Veracyte, Inc. Transaction History